Emerging therapies for herpes viral infections (types 1 - 8).

about

Sequential development of herpes zoster duplex unilateralis during oral famciclovir treatment.

P2860

Q46856748-4F70BA13-E071-49E5-A026-2F2E363CAD32

P2860

Emerging therapies for herpes viral infections (types 1 - 8).

Item

http://www.wikidata.org/entity/Q35967376

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Emerging therapies for herpes viral infections (types 1 - 8).

@ast

Emerging therapies for herpes viral infections (types 1 - 8).

@en

type

Item

label

Emerging therapies for herpes viral infections (types 1 - 8).

@ast

Emerging therapies for herpes viral infections (types 1 - 8).

@en

prefLabel

Emerging therapies for herpes viral infections (types 1 - 8).

@ast

Emerging therapies for herpes viral infections (types 1 - 8).

@en

P1476

Emerging therapies for herpes viral infections (types 1 - 8).

@en

P2093

Arun Chakrabarty

http://www.w3.org/2001/XMLSchema#string

David B Huang

http://www.w3.org/2001/XMLSchema#string

Jashin J Wu

http://www.w3.org/2001/XMLSchema#string

Julio Narvaez

http://www.w3.org/2001/XMLSchema#string

Karl R Beutner

http://www.w3.org/2001/XMLSchema#string

Katie R Pang

http://www.w3.org/2001/XMLSchema#string

Michael Rauser

http://www.w3.org/2001/XMLSchema#string

Stephen K Tyring

http://www.w3.org/2001/XMLSchema#string

P2860

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro

Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication

Selective activity of various antiviral compounds against HHV-7 infection

Biochemical basis for increased susceptibility to Cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activity

Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects.

Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs

Relation between herpes simplex viruses and human immunodeficiency virus infections.

P304

237-256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.9.2.237

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15571482

http://www.w3.org/2001/XMLSchema#string

Emerging therapies for herpes viral infections (types 1 - 8).

about

P2860

P2860

Emerging therapies for herpes viral infections (types 1 - 8).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698